FOLD Q2 2017 Earnings — Amicus Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

FOLDAmicus Therapeutics, Inc.

$5B

Q2 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$7M

Gross Profit

$6M85.2% margin

Operating Income

-$47M-657.5% margin

Net Income

-$48M-672.5% margin

EPS (Diluted)

$-0.34

QoQ Revenue Growth

+71.7%

Cash Flow

Operating Cash Flow

-$42M

Free Cash Flow

-$43M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$939M

Total Liabilities

$672M

Stockholders' Equity

$267M

Cash & Equivalents

$37M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7M	$0	—
Gross Profit	$6M	$0	—
Operating Income	-$47M	-$49M	+3.1%
Net Income	-$48M	-$51M	+5.7%